Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10168)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2020 (publication date) through Mar 25, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Watson C, Tallentire CW, Ramage JK, Srirajaskanthan R, Leeuwenkamp OR, Fountain D. Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review. World J Gastroenterol 2020; 26(25): 3686-3711 [PMID: 32742136 DOI: 10.3748/wjg.v26.i25.3686] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Watson C, Tallentire CW, Ramage JK, Srirajaskanthan R, Leeuwenkamp OR, Fountain D. Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review. World J Gastroenterol 2020; 26(25): 3686-3711 [PMID: 32742136 DOI: 10.3748/wjg.v26.i25.3686] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i25/3686.htm |
| Number | Citing Articles |
| 1 |
Håkan Ohlsson, Martin Nilsson, Anna Sundlöv, Marlene Malmström, Martin Almquist. Quality of life as a predictor for survival in patients with small intestinal neuroendocrine tumours. Journal of Neuroendocrinology 2025; 37(11) doi: 10.1111/jne.70081
|
| 2 |
Håkan Ohlsson, Anni Gålne, Elin Trägårdh, Marlene Malmström, Anna Sundlöv, Martin Almquist. Relationship between somatostatin receptor expressing tumour volume and health‐related quality of life in patients with metastatic GEP‐NET. Journal of Neuroendocrinology 2022; 34(6) doi: 10.1111/jne.13139
|
| 3 |
Giovanni Conzo, Federico Maria Mongardini, Maddalena Paolicelli, Michele Klain, Giuseppe Bellastella, Alessandra Conzo, Zhou Bo, Eduardo Lanza, Leandra Piscopo, Renato Patrone. Pancreatic Neuroendocrine Tumors: From Benchside to Surgical Treatment. Medicina 2026; 62(3): 479 doi: 10.3390/medicina62030479
|
| 4 |
Nehara Begum, Hannah Hunold, Berthold Gerdes, Tobias Keck, Annika Waldmann. Anxiety, Depression and Quality of Life in Patients with Neuroendocrine Neoplasia After Surgery. World Journal of Surgery 2022; 46(6): 1408 doi: 10.1007/s00268-022-06479-z
|
| 5 |
Elsa M. Ronde, Charlotte M. Heidsma, Anne M. Eskes, Josefine E. Schopman, Elisabeth J. M. Nieveen van Dijkum. Health‐related quality of life and treatment effects in patients with well‐differentiated gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis. European Journal of Cancer Care 2021; 30(6) doi: 10.1111/ecc.13504
|
| 6 |
Femke CR Staal, M Taghavi, Eun K Hong, Renaud Tissier, Mark van Treijen, Birthe C Heeres, Dennis van der Zee, Margot ET Tesselaar, Regina GH Beets-Tan, Monique Maas. CT-based radiomics to distinguish progressive from stable neuroendocrine liver metastases treated with somatostatin analogues: an explorative study. Acta Radiologica 2023; 64(3): 1062 doi: 10.1177/02841851221106598
|
| 7 |
Anna Caterina Milanetto, Claudia Armellin, Gloria Brigiari, Giulia Lorenzoni, Claudio Pasquali. Younger Age and Parenchyma-Sparing Surgery Positively Affected Long-Term Health-Related Quality of Life after Surgery for Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine 2023; 12(20): 6529 doi: 10.3390/jcm12206529
|
| 8 |
Marta Benavent, Javier Sastre, Ignacio García Escobar, Angel Segura, Jaume Capdevila, Alberto Carmona, Isabel Sevilla, Teresa Alonso, Guillermo Crespo, Lourdes García, Neus Canal, Guillermo de la Cruz, Javier Gallego. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS). Health and Quality of Life Outcomes 2021; 19(1) doi: 10.1186/s12955-021-01688-x
|
| 9 |
Boris G. Naraev, Josh Mailman, Thorvardur R. Halfdanarson, Heloisa P. Soares, Erik S. Mittra, Julie Hallet. Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors. Expert Review of Anticancer Therapy 2023; 23(6): 601 doi: 10.1080/14737140.2023.2207829
|
| 10 |
Jiarui Li, Yuejuan Cheng, Chunmei Bai, Jianming Xu, Lin Shen, Jie Li, Zhiwei Zhou, Zhiping Li, Yihebali Chi, Xianjun Yu, Enxiao Li, Nong Xu, Tianshu Liu, Wenhui Lou, Yuxian Bai, Xianglin Yuan, Xiuwen Wang, Ying Yuan, Jia Chen, Sha Guan, Songhua Fan, Weiguo Su. Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep). European Journal of Cancer 2022; 169: 1 doi: 10.1016/j.ejca.2022.03.027
|
| 11 |
Nynne Emilie Hummelshøj, Henning Gronbaek, Palle Bager, Elizaveta Tabaksblat, Gitte Dam. Fatigue and quality of life in patients with neuroendocrine neoplasia. Scandinavian Journal of Gastroenterology 2023; 58(1): 45 doi: 10.1080/00365521.2022.2100228
|
| 12 |
Anna Caterina Milanetto, Claudia Armellin, Daniele Gasparini, Giulia Lorenzoni, Claudio Pasquali. Quality of Life After Pancreatic Surgery for Neuroendocrine Tumors of the Pancreas: Observational Study of Long-Term Outcomes. Cancers 2025; 17(19): 3205 doi: 10.3390/cancers17193205
|
| 13 |
Mark Lewis, Jessica S. Thomas, Lisa Yen. Radioligand Therapy and Sequencing in Gastroenteropancreatic Neuroendocrine Tumors: A Patient Perspective Review. JCO Oncology Practice 2025; doi: 10.1200/OP-25-00474
|
| 14 |
Yin Shen, Zhi Zhang, Lingchao Kong, Yan Liu, Yimin Ma, Zhenguo Qiao, Guirong Qian. Clinicopathologic features and long term prognosis of early onset gastroenteropancreatic neuroendocrine tumors. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04644-7
|
| 15 |
Hans-Peter Kapfhammer. Depression, Angst, traumatischer Stress und internistische Erkrankungen. 2022; : 475 doi: 10.1007/978-3-662-65873-4_7
|
| 16 |
Yipu Wang, Gongning Wang, Chao Song, Wenqian Ma, Xiuli Zheng, Shuo Guo, Qi Wang, Lan Zhang, Limian Er. Dynamic nomogram for predicting the overall survival and cancer-specific survival of patients with gastrointestinal neuroendocrine tumor: a SEER-based retrospective cohort study and external validation. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1594591
|
| 17 |
Stefano Partelli, Detlef K. Bartsch, Massimo Falconi, Ashley Grossman, Ulrich Knigge, Seppo W. Langer, Wendy Martin, Dermot O'Toole, Aurel Perren, Joerg Schrader, Peter Stalberg, Thomas Walter, Eva Tiensuu Janson. Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours. Journal of Neuroendocrinology 2026; 38(3) doi: 10.1111/jne.70156
|